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Abstract
Background: objective measures of physical activity and function with a diverse cohort of UK adults in their 70s and 80s
were used to investigate relative risk of all-cause mortality and diagnoses of new diseases over a 4-year period.
Participants: two hundred and forty older adults were randomly recruited from 12 general practices in urban and suburban
areas of a city in the United Kingdom. Follow-up included 213 of the baseline sample.
Methods: socio-demographic variables, height and weight, and self-reported diagnosed diseases were recorded at baseline.
Seven-day accelerometry was used to assess total physical activity, moderate-to-vigorous activity and sedentary time. A log
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recorded trips from home. Lower limb function was assessed using the Short Physical Performance Battery. Medical records
were accessed on average 50 months post baseline, when new diseases and deaths were recorded.
Analyses: ANOVAs were used to assess socio-demographic, physical activity and lower limb function group differences in dis-
eases at baseline and new diseases during follow-up. Regression models were constructed to assess the prospective associations
between physical activity and function with mortality and new disease.
Results: for every 1,000 steps walked per day, the risk of mortality was 36% lower (hazard ratios 0.64, 95% conﬁdence interval
(CI) 0.44–0.91, P = 0.013). Low levels of moderate-to-vigorous physical activity (incident rate ratio (IRR) 1.67, 95% CI
1.04–2.68, P= 0.030) and low frequency of trips from home (IRR 1.41, 95% CI 0.98–2.05, P = 0.045) were associated with
diagnoses of more new diseases.
Conclusion: physical activity should be supported for adults in their 70s and 80s, as it is associated with reduced risk of
mortality and new disease development.
Keywords: older adults, physical activity, physical function, mortality, newly diagnosed disease
Introduction
The value of physical activity for the prevention of coronary
heart disease, stroke, type 2 diabetes and some cancers is
now well established for the adult population [1, 2]. Further
beneﬁts are seen in middle to later life as activity reduces risk
of physical disability [3], and cognitive impairment, dementia
and Alzheimer’s disease [4]. Evidence is also emerging of the
detrimental health effects of sedentary time, independent of
physical activity [5].
Older adults are the least active sector of society. In the
United Kingdom, <30% of 65–74 year olds and 15% of
adults aged 75 or over reported any moderate intensity phys-
ical activity lasting at least 10 min in the previous 4 weeks [6].
They are also the most sedentary sector, with US adults aged
60–69 spending over 8 h per day being sedentary [7]. Given
that the older sector of the population is expanding and
living longer, the promotion of active lifestyles has potential
to extend life and reduce disease and disability.
Surprisingly, few studies have investigated the impact of
physical activity on mortality and morbidity among those
already in their late 70s and 80s [8–12]. These studies have
included adults in their 60s, relied on self-reported physical
activity and have yielded equivocal results. In contrast, recent
systematic reviews of studies employing objective measures of
physical function have shown that lower grip strength, walking
speed, leg strength and balance are associated with higher risk
of mortality in the over 70s [13]. A similar review investigating
the prospective associations between these aspects of function
and health outcomes identiﬁed effects for grip strength and
walking speed on reduced risk of fracture, but associations
with cardiovascular disease and stroke were inconclusive [14].
Physical activity and aspects of function are also moder-
ately related [15] and can have reciprocal effects on each
other. Low activity contributes to mobility deterioration and
higher activity can improve or maintain mobility [16].
Conversely, mobility limitations, which might arise from con-
ditions such as osteoarthritis or heart conditions can also
have a detrimental effect on physical activity [17]. To separate
effects of activity from function, it is therefore important to
provide robust assessments of both physical activity and
function when investigating mortality and disease outcomes.
Concern has been expressed about the absence of use of
objective measures for the assessment of physical activity
when investigating mortality and morbidity in older adults
[18]. Self-report is susceptible to socially desirable responding
[19], and older adults have less accurate recall [20], and their
physical activity is mainly walking which is less memorable
than activity for leisure or ﬁtness [21]. Accelerometry provides
high precision data which can assess minute-by-minute activity
at different levels of intensity, sedentary time and numbers of
steps walked. This could be useful in helping identify whether
particular levels of intensity are related to health beneﬁt.
Similarly, simple, home-based batteries of tests are available
that provide valid estimates of several elements of function
that reﬂect tasks of daily living and mobility [22].
The evidence base for the beneﬁts of physical activity and
good physical function remains limited for those already well
into older age. This study focused on a population of UK older
adults at least 70 years old (mean 78 years). Objective measures
of both physical activity and lower limb function were employed
to assess their inﬂuence on relative risk for all-cause mortality
and diagnoses of new diseases over the following 4-year period.
Methods
Project OPAL (Older People and Active Living) was an ob-
servational study conducted in 2007/08 with 240 adults aged
70 and older, living in suburban and urban sectors of a large
city in south west England. The aim of OPAL was to provide
comprehensive objective documentation of physical activity
and lower limb function in older people and to identify pos-
sible determinants and consequences for health and well-
being [15, 21, 23, 24]. OPAL-PLUS was a follow-up study
that provided health data from primary care records over the
following 4–5 years [25]. Ethics approval for both studies
was obtained from Bristol Southmead NHS (Ethics refer-
ence 06/Q2002/127).
Sample
OPAL participants were recruited from 12 general practitioner
(GP) surgeries, stratiﬁed by low, medium or high Index of
Multiple Deprivation (IMD) and low or high access to local
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amenities. The sample was selected at random from the list of
patients aged 70 or older at each practice following screening by
a GP for (i) recent bereavement, (ii) terminal illness, (iii) debili-
tating mental illness, (iv) inability to complete a questionnaire
and (v) any other illness preventing participation. The ﬁnal
OPAL sample consisted of 115 females and 125 males. Age
and gender of the sample were similar in distribution to those
of the patient lists from which they were drawn. Percentages of
either overweight or obese were similar to national distributions
for England [6]. Also, the IMDs of participants’ residence pro-
vided a fair representation of the national IMD quartiles [26]
(22.1% [lowest]; 27.9, 31.3 and 18.7% [highest]).
Baseline measures
OPAL baseline data were collected through two home visits
as in Ref. [23]. For this paper, age (≤75.0–79.9, 80.0–84.9
and ≥85.0 years), gender, highest level of education attained
(primary, secondary or tertiary), weight status calculated
from measured height and weight (obese—body mass index
(BMI) ≥30.0 kg/m2; overweight—BMI 25.0–29.9 kg/m2;
normal/underweight—BMI <25.0 kg/m2), tertiles of IMD
of area of residence and number of self-reported diagnosed
conditions or diseases were used.
Physical activity
Physical activity was assessed by 7-day accelerometry using
Actigraph GT1Ms (http://www.actigraphcorp.com) pro-
grammed to record in 10-s epochs, to produce both count
and pedometer data [24]. Data were reduced using MAH/
UFFE Analyser v. 1.9.0.3 (MRC Epidemiology Unit) set to
ignore runs of 100 or more zeros, representing time when
the monitor was not worn. Inclusion required at least 10 h of
monitoring on at least 5 days. Daily means for registered
wear time per day, total minutes of activity at moderate-
to-vigorous intensity (MVPA) (>1,951 CPM), number of
steps (STEPS) and minutes of sedentary time (0–99 CPM)
were calculated. Additionally, a 7-day journey log recording
time, purpose and transport mode of trips from the home
was administered [21] and mean weekly frequency of trips
from home (TRIPS) calculated.
Physical function
Participants’ lower limb function was assessed using the Short
Physical Performance Battery (SPPB) [2] that includes home-
based tests of leg strength, walking speed and balance. These
were summed to produce a lower limb function score.
Follow-up data
Data were extracted in October 2012 from the medical
records of 213 (104 females) of the original 240 OPAL partici-
pants (3 were withdrawn by their GPs, 21 withdrew by choice
and 3 were not contactable). Mean lapse time since OPAL
baseline assessment was 50 (±14) months. Number of new
diagnoses of the chronic illnesses/conditions collected by the
Quality Outcomes Framework in primary care (2011–12) [27]
and date and cause of any death were recorded.
Data analyses
For ease of interpretation, STEPS representing activity
volume, TRIPS indicating mobility from home and sedentary
time were grouped into tertiles. MVPA was split into three
groups (<10, 10–29 and ≥30 min). Those in the most active
group were therefore reaching recommended amounts,
although this included all accumulated minutes rather than
those achieved in at least 10-min bouts. Three lower limb
function groups were formed (low: ≤6, medium: 7–9, high:
10–12), which differentiate between levels of mobility disabil-
ity [22]. ANOVAs were used to assess group differences in
these variables in follow-up time, numbers of self-reported
disease at baseline and numbers of new diseases recorded
during follow-up.
Cox proportional hazard models were computed to
address the prospective associations between physical activity
and function variables at baseline and subsequent mortality.
Poisson regression models, which are better suited for count
data, were used to estimate associations with number of
newly diagnosed diseases. The incident rate ratios (IRRs) in-
dicate the number of newly diagnosed diseases per year for
low and medium groups compared with the high activity or
function (reference) group.
For mortality prediction, Model 1 was unadjusted, but for
number of newly diagnosed diseases, Model 1 was adjusted
for time lapse from baseline to follow-up, or point of death
or move to a different practice. Model 2 was adjusted for
confounders at baseline known to be associated with mortal-
ity and morbidity, including age, gender, educational attain-
ment, IMD, weight status and number of self-reported
diseases/conditions. Model 2 was also adjusted for the prac-
tice recording system from which the data were extracted,
because the four different systems we encountered produced
some signiﬁcant differences in disease diagnoses and health
service usage means [25].
To assess the effects of activity and function independent-
ly of each other, for the activity variables, Model 3 was
adjusted for lower limb function. For lower limb function, in
Model 3, STEPS as an indicator of activity volume was
adjusted for mortality, and MVPA as an indicator of higher
intensity activity was adjusted for new disease prediction.
These activity variables also emerged in Model 2 as the most
potent activity variables. All analyses were performed with
IBM SPSS 20.0.
Results
All 213 participants whose medical records were examined
provided complete physical function, height and weight, and
self-reported illnesses data at baseline. Two hundred and
eight also provided valid accelerometry data (7 of these did
not provide step data due to technical error). There were 33
deaths with a mean time from baseline of 29 (±19) months.
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There were no statistically signiﬁcant differences in any socio-
demographic variables, pre-existing disease, physical activity
or lower limb function between the 213 adults in the ﬁnal
sample and those lost to follow-up (n= 27). Zero-order corre-
lations between STEPS, MVPA, TRIPS and lower limb
function were r= 0.45–0.55, indicating a moderate univariate
association.
Mean follow-up times were not signiﬁcantly different for
any of the socio-demographic or weight status groups
(Table 1). Signiﬁcantly more pre-existing diseases were reported
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Follow-up time, baseline disease and new disease by socio-demographics, weight status, physical activity and lower
limb function groups
Variables Mean follow-up time(m) Mean (SD) number of
self-reported diseases at baseline
Mean annual number (SD) of new
disease diagnoses during follow-up
Age (n= 213)
70–74.9 (n= 78) 54 (11) 1.33 (1.10) 0.26 (0.43)
75–79.9 (n= 57) 52 (14) 1.27 (1.04) 0.24 (0.36)
80–84.9 (n= 53) 50 (16) 1.57 (1.27) 0.27 (0.29)
85+ (n= 25) 44 (20) 1.60 (1.44) 0.36 (0.53)
P= 0.017 P = 0.419 P= 0.645
Gender (n= 213)
Female (n= 104) 53 (14) 1.57 (1.28) 0.26 (0.30)
Male (n= 109) 50 (14) 1.26 (1.04) 0.27 (0.46)
P= 0.405 P = 0.054 P= 0.896
Educational attainment (n= 213)
Primary (n= 41) 52 (14) 1.54 (1.03)a 0.25 (0.22)
Secondary (n= 66) 49 (16) 1.64 (1.29) 0.31 (0.37)
Tertiary (n= 98) 53 (12) 1.18 (1.12) 0.23 (0.42)
P= 0.286 P = 0.036 P= 0.405
Index of Multiple Deprivation (n= 213)
Low (n= 68) 52 (14) 1.00 (0.93)b 0.26 (0.50)
Medium (n= 69) 49 (16) 1.67 (1.23) 0.29 (0.34)
High (n= 76) 53 (13) 1.54 (1.23) 0.25 (0.31)
P= 0.505 P = 0.002 P= 0.824
Body mass index (n= 213)
Normal/underweight (n= 73) 52 (12) 1.12 (1.14)b 0.23 (0.24)
Overweight (n= 80) 53 (14) 1.53 (1.22) 0.25 (0.40)
Obese (n= 60) 49 (17) 1.60 (1.09) 0.33 (0.50)
P= 0.407 P = 0.034 P= 0.294
Number of steps per day (n= 201)
Low (n= 64), <3,196 47 (18)b 1.8 (1.2)b 0.33 (0.41)c
Medium (n= 67), 3,196–5,170 54 (13) 1.2 (1.0) 0.27 (0.45)
High (n= 70), >5,170 55 (8) 1.1 (1.1) 0.15 (0.17)
P = 0.003 P = 0.001 P= 0.015
Minutes of MVPA per day (n= 208)
Low (n= 76), <10 49 (18) 2.0 (1.3)b 0.32 (0.40)c
Medium (n= 93), 10–29.99 53 (12) 1.2 (1.0) 0.25 (0.39)
High (n= 39), 30+ 52 (10) 0.9 (1.1) 0.12 (0.16)
P= 0.072 P < 0.001 P= 0.008
Minutes of sedentary time per day (n= 208)
Low (n= 69), <633 52 (14) 1.4 (1.2) 0.25 (0.43)
Medium (n= 70), 633–696 52 (14) 1.4 (1.0) 0.27 (0.35)
High (n= 69), >696 51 (15) 1.4 (1.3) 0.24 (0.33)
P= 0.737 P = 0.946 P= 0.921
Frequency of trips per week (n= 200)
Low (n= 75), <8 50 (17) 1.7 (1.3)b 0.28 (0.35)
Medium (n= 59), 8–12 53 (13) 1.3 (1.0) 0.31 (0.51)
High (n= 66), >12 54 (11) 1.2 (1.2) 0.16 (0.18)
P= 0.161 P = 0.049 P= 0.078
Lower limb function score (n= 213)
Low (27), <7 43 (20)b 1.6 (1.2) 0.34 (0.44)
Medium (48), 7–9 48 (18) 1.9 (1.3)d 0.44 (0.62)d
High (138), >9 54 (11) 1.2 (1.0) 0.19 (0.22)
P < 0.001 P < 0.001 P= 0.009
aLow and medium significantly different to high group.
bLow significantly different to medium and high group.
cLow significantly different to high group.
dMedium significantly different to high group.
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at baseline for lower education, higher IMD and BMI groups.
In contrast, no signiﬁcant differences in group means for any
socio-demographic variable or BMI groups were seen for
numbers of newly diagnosed diseases.
Physical activity, lower limb function and mortality
Table 2 shows the hazard ratios (HR) for all-cause mortality
by level of STEPS, MVPA, TRIPS, sedentary time and lower
limb function. A strong and signiﬁcantly increased risk was
seen for low levels of STEPS (HR [low versus high] 11.38,
95% CI 2.64–49.04, P = 0.001) and MVPA (HR [low versus
high] 5.56, 95% CI 1.30–23.72, P= 0.002) in the unadjusted
Model 1. For STEPS only, (HR [low versus high] 7.69, 95%
CI 1.43–41.20, P = 0.054) all-cause mortality remained mar-
ginally signiﬁcant in adjusted Model 2. There was no evi-
dence of an association with mortality for either volume of
sedentary time or for trip frequency. However, a strong effect
is seen in adjusted Model 2 (HR [low versus high] 5.30, 95%
CI 1.91–14.72, P = 0.006) for lower limb function. Analyses
(not shown) were repeated, treating physical activity as con-
tinuous variables and revealed similar associations in terms
of direction, magnitude and signiﬁcance. An exception to
this was for STEPS which reached statistical signiﬁcance in
Model 3 (additionally adjusted for lower limb function) (HR
0.64 per 1,000 STEPS/day, 95% CI 0.44–0.91, P = 0.013).
Physical activity, lower limb function and newly
diagnosed disease
Sixty-two per cent of participants had at least one new
disease diagnosed in follow-up. Of 210 newly diagnosed
diseases, 60 (30%) were cardiovascular related, 37 (17.4%)
arthritis, 35 (16.4%) cancer, 33 (15.5%) kidney disease and
18 (8.5%) some form of mental illness. Low-active and low-
function groups had signiﬁcantly more diseases at baseline.
Also, follow-up times differed across STEPS and lower limb
function groups and were therefore adjusted in the models
predicting new disease. Table 3 shows a signiﬁcantly increa-
sed risk for new diseases for low levels of MVPA (IRR 1.67,
95% CI 1.04–2.68, P = 0.030) and TRIPS per week (IRR
1.41, 95% CI 0.98–2.05, P= 0.045) even after adjustment
for all co-variates and lower limb function. No associations
were seen for sedentary time or lower limb function. Treating
physical activity as continuous variables (not shown) made
no difference to this pattern of associations.
Discussion
The beneﬁts of physical activity for the prevention of prema-
ture mortality and further morbidity, among people already
in their 70s and 80s, are not well established. In this study,
steps taken per day were signiﬁcantly predictive of mortality
with the risk being 36% lower for every 1,000 steps taken.
This ﬁnding supports Brown et al. [8] in a study with women
(mean age: 75 years) and men (mean age: 72 years) which
found risk reduction for mortality with low volumes of self-
reported activity.
Lower limb function also indicated a strong association.
Amount of walking is closely related to lower limb function,
and both have indicated associations with mortality in previ-
ous studies [8–12, 13].Model 3 of the regression analysis also
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Cox proportional regression models predicting all-cause mortality from baseline physical activity and lower limb
function
Variables Number of deaths Person years Model 1 HR (95% CIs) Model 2 HR (95% CIs) Model 3a HR (95% CIs)
Total steps per day (n= 201) P = 0.001 P = 0.054 P = 0.169
Low 18 252.18 11.38 (2.64–49.04) 7.69 (1.43–41.20) 5.46 (0.91–32.76)
Medium 8 298.20 4.26 (0.91–20.07) 3.99 (0.80–20.01) 3.90 (0.77–19.70)
High (ref.) 2 321.14 1.00 1.00 1.00
Minutes of MVPA per day (n= 208) P = 0.002 P = 0.070 P = 0.692
Low 22 308.80 5.56 (1.30–23.72) 3.67 (0.70–19.15) 1.84 (0.32–10.75)
Medium 8 414.40 1.59 (0.34–7.49) 1.25 (0.25–6.41) 1.19 (0.23–6.24)
High (ref.) 2 171.18 1.00 1.00 1.00
Minutes of sedentary time per day (n= 208) P = 0.317 P = 0.888 P < 1.000
Low 7 272.05 0.51 (0.21–1.26) 0.81 (0.29–2.24) 1.01 (0.35–2.98)
Medium 10 307.80 0.69 (0.31–1.54) 1.04 (0.42–2.55) 0.99 (0.39–2.58)
High (ref.) 15 309.91 1.00 1.00 1.00
Frequency of trips per week (n= 200) P = 0.237 P = 0.808 P = 0.461
Low 18 383.50 1.57 (0.66–3.76) 0.98 (0.36–2.65) 0.51 (0.17–1.55)
Medium 5 246.19 0.71 (0.22–2.23) 0.71 (0.21–2.37) 0.52 (0.14–1.93)
High (ref.) 7 238.77 1.00 1.00 1.00
Lower limb function score (n= 213) P < 0.001 P = 0.006 P = 0.507
Low 11 98.06 5.68 (2.50–12.89) 5.30 (1.91–14.72) 2.05 (0.56–7.51)
Medium 10 191.69 2.79 (1.21–6.47) 2.58 (0.89–7.52) 1.69 (0.49–5.83)
High (ref.) 12 623.76 1.00 1.00 1.00
HR, hazards ratio with confidence intervals (CIs).
Model 1: unadjusted; Model 2: adjusting for age, gender, educational attainment, IMD, weight status, GP Management System and number of self-reported chronic
illnesses at baseline; Model 3: additionally adjusting for lower limb function.
aIn Model 3 for lower limb function additionally adjusting for STEPS.
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indicated a degree of co-dependency in the prediction of
mortality. There are many reasons why older adults lose
lower limb function including osteoarthritis and falls, but
physical activity is the most effective way of retaining func-
tion. These ﬁndings suggest that the maintenance of a mod-
erate volume of walking may therefore be a key factor for
reducing risk of premature mortality, even at this later stage
of life. Furthermore, there is evidence from the LIFE project
in the United States that lower limb function can be main-
tained or improved in older adults in their 70s and 80s
through a regular programme of structured exercise [16].
Amount of moderate-to-vigorous physical activity was a
signiﬁcant predictor of number of newly diagnosed diseases,
even after adjustment for existing disease and lower limb
function. This is in line with the evidence base underpinning
current physical activity guidelines indicating that the main
disease-related beneﬁts are seen with 30 min of MVPA activ-
ity each day [1, 2]. It also corroborates previous results with
OPAL participants showing that MVPA is an independent
predictor of aspects of health service usage [25]. In our
regressions, the high MVPA reference group included those
who achieved 30 min per day (50.1 ± 25.4), compared with
low and medium groups with mean MVPA of 3.7 and
18.1 min, respectively. However, only three individuals
reached the high MVPA group volume through bouts lasting
at least 10 min that features in guidelines. This is reﬂected
in ﬁndings from a recent national survey in the United
Kingdom, also based on accelerometry [28], showing only
7% of men and 3% of women met recommended amounts
through 10-min bouts. Our results suggest that for adults of
this age, the recommended amount of MVPA is beneﬁcial
even if it is accumulated in short bouts. Our previous
analyses of the OPAL cohort data indicated that the bulk of
total activity and MVPA was accumulated through active
daily journeys for shopping and visiting friends [21]. ‘Walk
and rest for a minute’ may be a useful strategy for adults in
this age group, particularly those working towards the recom-
mended targets.
A surprising ﬁnding is that the frequency of trips from
home also emerged as an independent predictor of newly diag-
nosed disease. The association of frequency of trips with
MVPA was moderate (r= 0.44), a ﬁnding recently supported
by national-level accelerometry data [28]. However, our
measure included all trips from the home regardless of the
mode of transport, so that car and bus journeys were included.
The higher tertile (reference group) included 12 (mean =
15.95) or more trips per week, and it is likely to be made up of
people with socially involved lives which itself is related to
reduced risk of mortality [29].
Although OPAL participants spent on average 11 h per
day sedentary, our data showed no associations for sedentary
time. Volume of sedentary time showed limited variance, with
a standard deviation of <10% within each level, and this may
have inﬂuenced its predictive power. Furthermore, the identiﬁ-
cation of sedentary time by use of accelerometer counts of 0–
99 per minute has been challenged and may lack validity [30].
Limitations
The sample size of 213 was small compared with most pro-
spective cohort studies. Although the strength of OPAL-
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Table 3. Poisson regression models predicting number of newly diagnosed chronic illnesses from baseline physical activity and
lower limb function
Variables Model 1 IRR (95% CIs) Model 2 IRR (95% CIs) Model 3a IRR (95% CIs)
Total steps per day (n= 201) P = 0.119 P= 0.074 P= 0.078
Low 1.39 (0.99–1.95) 1.32 (0.90–1.95) 1.28 (0.83–1.96)
Medium 1.40 (0.99–1.98) 1.48 (1.06–2.08) 1.47 (1.05–2.07)
High (ref.) 1.00 1.00 1.00
Minutes of MVPA per day (n= 208) P = 0.017 P = 0.023 P= 0.030
Low 1.79 (1.17–2.73) 1.79 (1.13–2.83) 1.67 (1.04–2.68)
Medium 1.76 (1.16–2.66) 1.79 (1.17–2.74) 1.78 (1.16–2.72)
High (ref.) 1.00 1.00 1.00
Minutes of sedentary time per day (n= 208) P = 0.647 P= 0.810 P= 0.757
Low 1.15 (0.85–1.55) 1.07 (0.78–1.45) 1.09 (0.80–1.49)
Medium 1.04 (0.75–1.45) 0.96 (0.69–1.34) 0.97 (0.69–1.36)
High (ref.) 1.00 1.00 1.00
Frequency of trips per week (n= 200) P = 0.019 P = 0.043 P= 0.045
Low 1.51 (1.09–2.09) 1.48 (1.04–2.12) 1.41 (0.98–2.05)
Medium 1.57 (1.11–2.22) 1.54 (1.08–2.20) 1.57 (1.10–2.26)
High (ref.) 1.00 1.00 1.00
Lower limb function score (n= 213) P = 0.065 P= 0.171 P= 0.252
Low 1.12 (0.76–1.65) 1.15 (0.77–1.71) 1.10 (0.71–1.70)
Medium 1.38 (1.05–1.80) 1.36 (0.99–1.86) 1.32 (0.95–1.83)
High (ref.) 1.00 1.00 1.00
IRR, incident rate ratio with confidence intervals (CIs).
Model 1: adjusting for time to follow-up; Model 2: adjusting for time to follow-up, age, gender, educational attainment, IMD, weight status, GP Management System
and number of self-reported chronic illnesses at baseline; Model 3: additionally adjusting for lower limb function.
aIn Model 3 for lower limb function additionally adjusting for MVPA.
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PLUS was the objective assessment of physical activity and
function, accelerometry requires cut points in movement
counts to deﬁne MVPA and sedentary time. For older adults,
these are based on very limited data and may be prone to
misclassiﬁcation.
Mortality and disease have some co-dependence, and this
may have inﬂuenced our results. Those who died early have
had less time to contract new disease, whereas those who are
already at risk of premature mortality may contract new con-
ditions at a more rapid rate. Our analyses indicated that sig-
niﬁcantly more new diseases were recorded for those who
died than survivors, even within a shorter follow-up.
However, our regression results were unaffected, possibly
because there were only 33 deaths.
A particular challenge with prospective cohort studies is
the possibility of unmeasured, or poorly measured, factors
being the true explanation of associations. Although we
adjusted regressions for most established confounders, we
did not include smoking or alcohol consumption. Also, there
is a possibility that unidentiﬁed subclinical disease at baseline
was associated with lower activity levels, and this may con-
tribute to some associations.
Conclusions
Even in this relatively small sample, the beneﬁts of physical
activity for reduced risk of premature mortality and further
development of disease in older adults in their 70s and 80s
can be seen. Volume of activity and amount of MVPA both
emerge as important, with the effect for MVPA seen inde-
pendently of lower limb function and even if it is accumu-
lated in bouts shorter than 10 min. These ﬁndings indicate
that physical activity should be encouraged in adults through-
out their 70s and 80s, regardless of level of lower limb func-
tion and existing disease.
Key points
• The health beneﬁts of physical activity for adults in their
70s and 80s are not established.
• Objective measures of activity and function have not been
used in prospective studies with this age group.
• Volume of activity (as measured by steps per day) and
function are predictive of reduced risk of mortality.
• Moderate-to-vigorous activity is predictive of reduced risk
of new disease diagnosis, independent of lower limb
function.
• Physical activity is beneﬁcial for this age group regardless
of socio-demographic characteristics, function and disease
status.
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